Acotec Scientific Holdings Limited announced that on December 23, 2022, the Group received the registration approvals from the PRC National Products Administration for YAN, a product designed for dilation in coronary artery or coronary artery bypass vessels stenosis to improve myocardial perfusion. YAN is also indicated for dilation of coronary artery occlusive lesions to restore coronary blood flow of ST-segment elevation myocardial infarction (STMI) patients. The Company will carry out marketing activities in PRC market when appropriate.